http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2483671-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39fbb61f03c33afa6c51525fdd2d16d3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 |
| filingDate | 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9db6490919e8446c9bb0bba2f3d996c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54a34dd4d03772f6971239267105635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e5409b3137aab9b3b27ac9070a0cf5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa1736ca4566abf4e00c09918f3a8d95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ad47c49ba16c9130d6f89e9b227eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52cf26f62f2b051540882a9e8fed1aca |
| publicationDate | 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2483671-C1 |
| titleOfInvention | Method of preventing acute coronary syndrome in men with arterial hypertension with moderate risk of development of acute cardiovascular complications |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to cardiology, and can be used for prevention of acute coronary syndrome in men with arterial hypertension, with moderate risk of acute cardiovascular complications. Multispiral computed tomography is carried out and total volume of calcium or total calcium index is determined by Agatson. Value of total calcium volume higher than 1222 or total calcium index higher than 1519 is considered to be significant additional factor. Such patients are additionally given therapy with acetylsalicylic acid. n EFFECT: method extends indications for carrying out said therapy with moderate cardiovascular risk and asymptomatic course of atherosclerosis, which ensures prevention of acute coronary syndrome in such patients. n 2 tbl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2741195-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2557702-C1 |
| priorityDate | 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.